NCT00001933View on ClinicalTrials.gov

Nefiracetam in the Treatment of Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

January 31, 2002

Conditions
Alzheimer's Disease
Interventions
DRUG

Nefiracetam

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00001933 - Nefiracetam in the Treatment of Alzheimer's Disease | Biotech Hunter | Biotech Hunter